Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms

Eigild Møller, Merete Karlsborg, Allan Bardow, Joan Lykkeaa, Flemming H Nissen, Merete Bakke

23 Citationer (Scopus)

Abstract

Drooling in neurodegenerative diseases is associated with social impediment. Previous treatments of drooling have little effect or are effective but with severe side effects. Therefore, there is a need to test new methods such as the use of botulinum toxin type A (BTX-A).
OriginalsprogEngelsk
TidsskriftActa Odontologica Scandinavica
Vol/bind69
Udgave nummer3
Sider (fra-til)151-7
Antal sider7
ISSN0001-6357
DOI
StatusUdgivet - 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms'. Sammen danner de et unikt fingeraftryk.

Citationsformater